US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
US6223786B1
(en)
|
1998-11-14 |
2001-05-01 |
Pen Jet Corporation |
Apparatus and method for mixing medication and filling an ampule of a needle-less injector
|
US6474369B2
(en)
|
1995-05-26 |
2002-11-05 |
Penjet Corporation |
Apparatus and method for delivering a lyophilized active with a needle-less injector
|
FR2739562B1
(en)
*
|
1995-10-09 |
1998-04-24 |
Moreau Defarges Alain |
JET INJECTION DEVICE WITHOUT NEEDLE, INCLUDING AN OVER-MOLDED CARTRIDGE
|
US6080130A
(en)
*
|
1998-11-14 |
2000-06-27 |
Castellano; Thomas P. |
Gas power source for a needle-less injector
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
US6004287A
(en)
*
|
1997-09-23 |
1999-12-21 |
Loomis; Dale J |
Biolistic apparatus for delivering substances into cells and tissues
|
DE19820172A1
(en)
*
|
1997-09-30 |
2005-01-27 |
Wolfgang Wagner |
Injection arrangement for inserting a diagnostic carrier or medicament beneath a patient's skin has a compressed gas source and a valve closure for controlling the release of the gas that is used to inject a substance
|
US6610042B2
(en)
|
1997-12-05 |
2003-08-26 |
Felton Medical, Inc. |
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
|
US6156008A
(en)
*
|
1998-05-04 |
2000-12-05 |
Castellano; Thomas P. |
Device for avoiding subdermal hematomas from an injection
|
AU5317699A
(en)
*
|
1998-07-27 |
2000-02-21 |
Medi-Ject Corporation |
Loading mechanism for medical injector assembly
|
US6264629B1
(en)
|
1998-11-18 |
2001-07-24 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6783509B1
(en)
|
1998-11-18 |
2004-08-31 |
Bioject Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6689093B2
(en)
|
1998-11-18 |
2004-02-10 |
Bioject, Inc. |
Single-use needle-less hypodermic jet injection apparatus and method
|
US6406455B1
(en)
*
|
1998-12-18 |
2002-06-18 |
Biovalve Technologies, Inc. |
Injection devices
|
DE19859137C1
(en)
*
|
1998-12-21 |
2000-05-18 |
Ferton Holding Sa |
High pressure medicinal injection unit includes piston advanced into pressure chamber by series of resilient impacts, forcing fluid out in series of impulses for precise low-volume dosing
|
US7060048B1
(en)
*
|
1999-04-16 |
2006-06-13 |
Powerject Research Limited |
Needleless syringe
|
US6689095B1
(en)
*
|
1999-04-22 |
2004-02-10 |
Gilbert Garitano |
Needleless permanent makeup and tattoo device
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
ATE342089T1
(en)
*
|
1999-06-02 |
2006-11-15 |
Boston Scient Ltd |
DRUG DELIVERY DEVICES
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
US20010027293A1
(en)
*
|
1999-06-29 |
2001-10-04 |
Ashok V. Joshi |
Storage stable fluid injection device and associated process
|
US6802826B1
(en)
|
1999-10-11 |
2004-10-12 |
Felton International, Inc. |
Universal anti-infectious protector for needleless injectors
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6776776B2
(en)
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
FI115664B
(en)
*
|
1999-10-20 |
2005-06-15 |
Uponor Innovation Ab |
connecting portion
|
US6673035B1
(en)
|
1999-10-22 |
2004-01-06 |
Antares Pharma, Inc. |
Medical injector and medicament loading system for use therewith
|
FR2800619B1
(en)
*
|
1999-11-05 |
2002-02-08 |
Cross Site Technologies |
NEEDLELESS SYRINGE WITH TEMPORARILY RETAINED PUSHING MEDIA
|
US6254579B1
(en)
*
|
1999-11-08 |
2001-07-03 |
Allergan Sales, Inc. |
Multiple precision dose, preservative-free medication delivery system
|
DE19955201A1
(en)
*
|
1999-11-16 |
2001-05-31 |
Roesch Ag Medizintechnik |
Injection device
|
AU1927701A
(en)
*
|
1999-11-23 |
2001-06-04 |
Needleless Ventures, Inc. |
Injector assembly with driving means and locking means
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
WO2001051109A1
(en)
*
|
2000-01-07 |
2001-07-19 |
Biovalve Technologies, Inc. |
Injection device
|
US6210359B1
(en)
|
2000-01-21 |
2001-04-03 |
Jet Medica, L.L.C. |
Needleless syringe
|
FR2804869B1
(en)
*
|
2000-02-11 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
NEEDLELESS SYRINGE FOR THE INJECTION OF A LIQUID CONTAINED IN A PRE-FILLED BULB
|
JP2003529417A
(en)
*
|
2000-03-23 |
2003-10-07 |
アンタレス・ファーマ・インコーポレーテッド |
One-time use disposable jet syringe
|
FR2809626B1
(en)
*
|
2000-05-30 |
2003-03-07 |
Poudres & Explosifs Ste Nale |
NEEDLELESS SYRINGE WITH MULTI-DUCT EJECTOR INSULATION MEMBRANE
|
US6629958B1
(en)
|
2000-06-07 |
2003-10-07 |
Ronald P. Spinello |
Leak sealing needle
|
US6406456B1
(en)
|
2000-06-08 |
2002-06-18 |
Avant Drug Delivery Systems, Inc. |
Jet injector
|
DE10029325A1
(en)
*
|
2000-06-20 |
2002-01-03 |
Peter Lell |
Needle-free injection device with pyrotechnic drive
|
FR2810554B1
(en)
*
|
2000-06-22 |
2003-05-16 |
Poudres & Explosifs Ste Nale |
SYRINGE WITHOUT NEEDLE PROVIDED WITH A MODULAR RESERVOIR
|
FR2812202B1
(en)
*
|
2000-07-28 |
2002-09-13 |
Poudres & Explosifs Ste Nale |
NEEDLELESS SYRINGE OPERATING BY COMPRESSION OF THE TANK CONTAINING THE LIQUID ACTIVE INGREDIENT
|
UA81743C2
(en)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
HUMAN MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TUMOR NECROSIS FACTOR ALFA (TNFα), PHARMACEUTICAL MIXTURE CONTAINING THEREOF, AND METHOD FOR TREATING ARTHRITIS
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
CA2324045A1
(en)
*
|
2000-10-20 |
2002-04-20 |
Universite De Sherbrooke |
No-needle syringe for the subcutaneous injection of medicated powders
|
AU2003222427B8
(en)
*
|
2000-11-17 |
2010-04-29 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
US8071740B2
(en)
*
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
US7931614B2
(en)
*
|
2000-11-30 |
2011-04-26 |
Valeritas, Inc. |
Injection systems
|
EP2269639B1
(en)
|
2001-02-23 |
2018-11-28 |
GlaxoSmithKline Biologicals s.a. |
Influenza vaccine formulations for intradermal delivery
|
US6645170B2
(en)
|
2001-03-05 |
2003-11-11 |
Bioject Medical Technologies, Inc. |
Simplified disposable needle-free injection apparatus and method
|
US6471669B2
(en)
|
2001-03-05 |
2002-10-29 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
US6500239B2
(en)
|
2001-03-14 |
2002-12-31 |
Penjet Corporation |
System and method for removing dissolved gas from a solution
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
JP2004526519A
(en)
|
2001-04-13 |
2004-09-02 |
ペンジェット・コーポレーション |
Modular gas pressure needleless syringe
|
US20050192530A1
(en)
*
|
2001-04-13 |
2005-09-01 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
US6613010B2
(en)
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
US6755220B2
(en)
|
2001-04-27 |
2004-06-29 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
US6752781B2
(en)
*
|
2001-06-08 |
2004-06-22 |
Sergio Landau |
Durable hypodermic jet injector apparatus and method
|
US7544188B2
(en)
*
|
2001-07-19 |
2009-06-09 |
Intelliject, Inc. |
Medical injector
|
CA2463816C
(en)
|
2001-10-19 |
2014-07-08 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
US6607510B2
(en)
|
2001-11-09 |
2003-08-19 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
DE10155344A1
(en)
*
|
2001-11-10 |
2003-05-28 |
Schott Glas |
Filled container for a subcutaneous jet injection system has a screw closure cap, of the same material as the container, with a centering unit to align a pin with the jet outlet opening for sealing
|
NZ533223A
(en)
|
2001-11-14 |
2007-04-27 |
Centocor Inc |
Anti-il-6 antibodies, compositions, methods and uses
|
KR20040099264A
(en)
*
|
2002-01-18 |
2004-11-26 |
이노비오 에이에스 |
Bispecific antibody dna constructs for intramuscular administration
|
JP3993169B2
(en)
|
2002-02-11 |
2007-10-17 |
アンタレス・ファーマ・インコーポレーテッド |
Intradermal syringe
|
AU2003209645A1
(en)
*
|
2002-03-04 |
2003-09-16 |
Nano Pass Technologies Ltd. |
Devices and methods for transporting fluid across a biological barrier
|
GB0206560D0
(en)
*
|
2002-03-20 |
2002-05-01 |
Glaxo Group Ltd |
Novel device
|
US20030196928A1
(en)
*
|
2002-04-19 |
2003-10-23 |
Parsons J. Stuart |
Multi-component ampule
|
US7601137B2
(en)
*
|
2002-06-10 |
2009-10-13 |
Intervet International B.V. |
Needle-less injector
|
CA2490409A1
(en)
|
2002-06-28 |
2004-01-08 |
Centocor, Inc. |
Mammalian ch1 deleted mimetibodies, compositions, methods and uses
|
AU2003243875B2
(en)
*
|
2002-07-11 |
2006-07-06 |
Tecpharma Licensing Ag |
Needle-free injection device
|
US7081109B2
(en)
*
|
2002-08-22 |
2006-07-25 |
Baxa Corporation |
Sterile docking apparatus and method
|
JP2005536273A
(en)
|
2002-08-26 |
2005-12-02 |
ペンジェット・コーポレーション |
Device for needle-free injection with deaerated fluid
|
FR2852517B1
(en)
*
|
2003-03-21 |
2005-11-11 |
|
INJECTION DEVICE WITHOUT NEEDLE WITH PYROTECHNIC CARTRIDGE AND METHOD FOR ASSEMBLING SUCH A DEVICE
|
EP1624938B1
(en)
*
|
2003-05-20 |
2011-03-16 |
James F. Collins |
Ophthalmic drug delivery system
|
US8545463B2
(en)
*
|
2003-05-20 |
2013-10-01 |
Optimyst Systems Inc. |
Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device
|
EP1664322B1
(en)
|
2003-05-22 |
2013-07-10 |
Fraunhofer USA, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
WO2004112871A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Allergan, Inc. |
Needless injectors
|
AU2004268457A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Anges Mg, Inc. |
Gene therapy for skin disorders using needleless syringes
|
WO2005034949A1
(en)
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
IL157984A
(en)
|
2003-09-17 |
2015-02-26 |
Dali Medical Devices Ltd |
Autoneedle
|
IL157981A
(en)
|
2003-09-17 |
2014-01-30 |
Elcam Medical Agricultural Cooperative Ass Ltd |
Auto-injector
|
JP5122142B2
(en)
|
2003-11-05 |
2013-01-16 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Stabilized α-helix peptides and methods of use thereof
|
WO2005049107A2
(en)
*
|
2003-11-18 |
2005-06-02 |
Nanapass Technologies Ltd. |
Enhanced penetration system and method for sliding microneedles
|
WO2005056077A2
(en)
|
2003-12-05 |
2005-06-23 |
Aradigm Corporation |
A device for readying a needle free injector for delivery
|
EP1722842A1
(en)
*
|
2004-01-26 |
2006-11-22 |
The Medical House Plc |
Needle-free injection device
|
US7717879B2
(en)
*
|
2004-02-03 |
2010-05-18 |
Smjm Inject Gmbh |
Anesthetic syringe
|
IL160891A0
(en)
|
2004-03-16 |
2004-08-31 |
|
Auto-mix needle
|
CA2563379A1
(en)
*
|
2004-03-31 |
2005-10-20 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
US20070299392A1
(en)
*
|
2004-07-14 |
2007-12-27 |
By-Pass, Inc. |
Material Delivery System
|
US7910787B2
(en)
*
|
2004-07-29 |
2011-03-22 |
Gas Technologies Llc |
Method and system for methanol production
|
US9180426B2
(en)
|
2004-07-29 |
2015-11-10 |
Gas Technologies, Llc |
Scrubber for methanol production system
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
CA2580137A1
(en)
|
2004-09-22 |
2006-03-30 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US7648483B2
(en)
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US7648482B2
(en)
*
|
2004-11-22 |
2010-01-19 |
Intelliject, Inc. |
Devices, systems, and methods for medicament delivery
|
US11590286B2
(en)
|
2004-11-22 |
2023-02-28 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
US7947017B2
(en)
|
2004-11-22 |
2011-05-24 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US10737028B2
(en)
|
2004-11-22 |
2020-08-11 |
Kaleo, Inc. |
Devices, systems and methods for medicament delivery
|
CN101087625B
(en)
|
2004-11-22 |
2012-02-22 |
因特利杰克特有限公司 |
Devices and systems for medicament delivery
|
WO2006083876A2
(en)
|
2005-02-01 |
2006-08-10 |
Intelliject, Llc |
Devices, systems, and methods for medicament delivery
|
BRPI0515759B8
(en)
*
|
2004-12-01 |
2021-06-22 |
Acushot Inc |
needleless injection device and kit for using it
|
CN101132820B
(en)
|
2005-01-24 |
2010-05-19 |
安塔雷斯制药公司 |
Prefilled needle assisted jet injector
|
US9022980B2
(en)
|
2005-02-01 |
2015-05-05 |
Kaleo, Inc. |
Medical injector simulation device
|
US8231573B2
(en)
|
2005-02-01 |
2012-07-31 |
Intelliject, Inc. |
Medicament delivery device having an electronic circuit system
|
US7731686B2
(en)
|
2005-02-01 |
2010-06-08 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US8206360B2
(en)
|
2005-02-01 |
2012-06-26 |
Intelliject, Inc. |
Devices, systems and methods for medicament delivery
|
US8361026B2
(en)
|
2005-02-01 |
2013-01-29 |
Intelliject, Inc. |
Apparatus and methods for self-administration of vaccines and other medicaments
|
CA2603180C
(en)
|
2005-03-23 |
2015-10-13 |
Glaxosmithkline Biologicals S.A. |
Influenza vaccine compositions and method for immunization against influenza disease
|
ES2732625T3
(en)
|
2005-04-04 |
2019-11-25 |
Univ Florida |
Desferritiocin polyether analogs
|
PE20061324A1
(en)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
US7611505B2
(en)
*
|
2005-05-10 |
2009-11-03 |
Baxa Corporation |
Sterile docking apparatus and method
|
EP2452694B1
(en)
|
2005-06-30 |
2018-11-14 |
Janssen Biotech, Inc. |
Anti-IL-23 antibodies, compositions, methods and uses
|
CN101378781B
(en)
|
2005-08-03 |
2013-08-07 |
美国弗劳恩霍夫股份有限公司 |
Compositions and methods for production of immunoglobulins
|
US20070055200A1
(en)
*
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Needle-free jet injection drug delivery device
|
TWI457133B
(en)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
Novel composition
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AR058592A1
(en)
|
2005-12-22 |
2008-02-13 |
Glaxosmithkline Biolog Sa |
VACCINE
|
PT3219328T
(en)
|
2005-12-29 |
2020-08-28 |
Janssen Biotech Inc |
Human anti-il-23 antibodies, compositions, method and uses
|
AU2007215080A1
(en)
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
KR101541383B1
(en)
|
2006-03-30 |
2015-08-03 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
immunogenic composition
|
CA2648035A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Centocor, Inc. |
Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
|
ES2776100T3
(en)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
System for targeted delivery of therapeutic agents
|
US20070254381A1
(en)
*
|
2006-04-27 |
2007-11-01 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Monitoring and/or treating syringe mechanism
|
WO2007131013A1
(en)
|
2006-05-03 |
2007-11-15 |
Antares Pharma, Inc. |
Two-stage reconstituting injector
|
US20070260174A1
(en)
*
|
2006-05-05 |
2007-11-08 |
Searete Llc |
Detecting a failure to maintain a regimen
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
EP2030015B1
(en)
|
2006-06-02 |
2016-02-17 |
President and Fellows of Harvard College |
Protein surface remodeling
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
PT2422810E
(en)
|
2006-07-17 |
2014-12-03 |
Glaxosmithkline Biolog Sa |
Influenza vaccine
|
WO2008021367A2
(en)
|
2006-08-11 |
2008-02-21 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
DE202006018609U1
(en)
*
|
2006-08-29 |
2007-05-16 |
Euro-Celtique S.A. |
Needle-free apparatus for administrating pharmaceutical composition in humans, comprises a housing; auxiliary substance to force a pharmaceutical composition from a package into human body; a composition comprising analgesic, e.g. opioids
|
US7547293B2
(en)
*
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
JO3598B1
(en)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
Boronic acids and esters as inhibitors of fatty acid amide hydrolase
|
EP2086582B1
(en)
|
2006-10-12 |
2012-11-14 |
GlaxoSmithKline Biologicals s.a. |
Vaccine comprising an oil in water emulsion adjuvant
|
ES2397714T3
(en)
|
2006-10-12 |
2013-03-08 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising an oil-in-water emulsion adjuvant
|
DE202006017522U1
(en)
*
|
2006-11-15 |
2007-01-18 |
Perma-Tec Gmbh & Co. Kg |
Lubricant dispenser has at least one tooth arranged on periphery of piston and pressing against inside wall of lubricant reservoir, and consists of harder material in comparison to lubricant reservoir
|
CA2671447A1
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Amphiphilic entity nanoparticles
|
US20080140001A1
(en)
*
|
2006-12-12 |
2008-06-12 |
By-Pass Inc. |
Fluid Delivery Apparatus And Methods
|
UY30820A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Centocor Inc |
USE OF LONG-TERM ACTION GLP-1 RECEPTOR AGONISTS TO IMPROVE INSULIN SENSITIVITY AND LIPID PROFILES
|
KR20140140134A
(en)
|
2006-12-26 |
2014-12-08 |
랜티우스 메디컬 이메징, 인크. |
Ligands for imaging cardiac innervation
|
US20080171968A1
(en)
*
|
2007-01-15 |
2008-07-17 |
Bioject, Inc. |
Methods of administering injectables to a joint with a needle-free injection system
|
WO2008091838A2
(en)
|
2007-01-22 |
2008-07-31 |
Intelliject, Inc. |
Medical injector with compliance tracking and monitoring
|
US8889632B2
(en)
|
2007-01-31 |
2014-11-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
EP2134830A2
(en)
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
WO2008103997A2
(en)
*
|
2007-02-23 |
2008-08-28 |
Bioject Inc. |
Needle-free injection devices and drug delivery systems therefor
|
BRPI0809077A2
(en)
|
2007-03-15 |
2014-09-09 |
Univ Florida Res Foudantion Inc |
DEFERRITIOCINE Polyether ANALOGUE
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
ES2430067T3
(en)
|
2007-03-28 |
2013-11-18 |
President And Fellows Of Harvard College |
Sewn polypeptides
|
JP2010523595A
(en)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
Poly (amino acid) targeting part
|
EP2152301A4
(en)
|
2007-04-28 |
2010-07-28 |
Fraunhofer Usa Inc |
Trypanosoma antigens, vaccine compositions, and related methods
|
US8524444B2
(en)
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
WO2009000825A2
(en)
|
2007-06-26 |
2008-12-31 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
CA2692933C
(en)
|
2007-07-11 |
2016-10-18 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
US8604004B2
(en)
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
JP2011500569A
(en)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
Vaccine nanotechnology
|
CA2703393C
(en)
|
2007-11-02 |
2018-07-24 |
Talecris Biotherapeutics, Inc. |
Method, composition, and article of manufacture for providing alpha-1 antitrypsin
|
EP2214756A1
(en)
|
2007-11-19 |
2010-08-11 |
Painless Tech GmbH |
Injection device for the needle-free injection of a medium
|
AU2009204345A1
(en)
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
US20090212133A1
(en)
*
|
2008-01-25 |
2009-08-27 |
Collins Jr James F |
Ophthalmic fluid delivery device and method of operation
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
JP5637982B2
(en)
|
2008-04-09 |
2014-12-10 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Inhibitors of fatty acid amide hydrolase
|
EP2612680B1
(en)
|
2008-04-16 |
2018-05-23 |
GlaxoSmithKline Biologicals SA |
Vaccine
|
USD994111S1
(en)
|
2008-05-12 |
2023-08-01 |
Kaleo, Inc. |
Medicament delivery device cover
|
US8021344B2
(en)
|
2008-07-28 |
2011-09-20 |
Intelliject, Inc. |
Medicament delivery device configured to produce an audible output
|
US20090291986A1
(en)
|
2008-05-22 |
2009-11-26 |
Apostolos Pappas |
Composition and method of treating facial skin defect
|
CA3042777A1
(en)
|
2008-06-26 |
2009-12-30 |
Anterios, Inc. |
Dermal delivery
|
ES2442024T3
(en)
|
2008-07-15 |
2014-02-07 |
Academia Sinica |
Glucan matrices on glass slides coated with PTFE type aluminum and related methods
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
US8376993B2
(en)
|
2008-08-05 |
2013-02-19 |
Antares Pharma, Inc. |
Multiple dosage injector
|
CA2733642A1
(en)
|
2008-08-14 |
2010-02-18 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
AU2009293019A1
(en)
|
2008-09-19 |
2010-03-25 |
Tandem Diabetes Care Inc. |
Solute concentration measurement device and related methods
|
US9206223B2
(en)
|
2008-09-22 |
2015-12-08 |
Aileron Therapeutics, Inc. |
Methods for preparing purified polypeptide compositions
|
US8663196B2
(en)
*
|
2008-09-23 |
2014-03-04 |
Kassab Kughn Endovascular Devices Llc |
Endovascular sheath with gradable stiffness device and method
|
DE102008048595A1
(en)
|
2008-09-23 |
2010-04-01 |
Lts Lohmann Therapie-Systeme Ag |
Disposable injector with high injection safety
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
CA3149920A1
(en)
|
2008-10-31 |
2010-05-06 |
Janssen Biotech, Inc. |
Fibronectin type iii domain based scaffold compositions, methods and uses
|
EP2376089B1
(en)
|
2008-11-17 |
2018-03-14 |
The Regents of the University of Michigan |
Cancer vaccine compositions and methods of using the same
|
EP2376619A4
(en)
|
2008-12-15 |
2012-07-04 |
Greenlight Biosciences Inc |
Methods for control of flux in metabolic pathways
|
BRPI1006139A2
(en)
|
2009-01-14 |
2017-05-30 |
Aileron Therapeutics Inc |
peptidomimetic macrocycles
|
AU2010213892B2
(en)
|
2009-02-12 |
2014-10-23 |
Janssen Biotech, Inc. |
Fibronectin type III domain based scaffold compositions, methods and uses
|
AU2010226442A1
(en)
|
2009-03-20 |
2011-10-13 |
Antares Pharma, Inc. |
Hazardous agent injection system
|
IL197761A0
(en)
*
|
2009-03-23 |
2009-12-24 |
Moshe Zalsman |
Capsule for mixing together two flowable materials, and kits including such capsules, particularly useful in dentistry
|
WO2010129023A2
(en)
|
2009-04-28 |
2010-11-11 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
US8927551B2
(en)
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8765735B2
(en)
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
JP2012528858A
(en)
|
2009-06-01 |
2012-11-15 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
O-GlcNAc transferase inhibitor and use thereof
|
JP2012532929A
(en)
|
2009-07-13 |
2012-12-20 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
Bifunctional stapled polypeptides and their use
|
AU2010278894B2
(en)
|
2009-07-30 |
2014-01-30 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
EP2298390A1
(en)
*
|
2009-08-28 |
2011-03-23 |
Sanofi-Aventis Deutschland GmbH |
Medical delivery device, housing cap for a medical delivery device and drive mechanism for a medical delivery device
|
CA2774973A1
(en)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
EP2483307A1
(en)
|
2009-09-29 |
2012-08-08 |
Fraunhofer USA, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US20140200511A1
(en)
*
|
2009-10-30 |
2014-07-17 |
Searete Llc |
Systems, devices, and methods for making or administering frozen particles
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
JP6210685B2
(en)
|
2010-01-27 |
2017-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
AU2011213072C1
(en)
|
2010-02-03 |
2016-12-15 |
Infinity Pharmaceuticals, Inc. |
Fatty acid amide hydrolase inhibitors
|
EP2533814A2
(en)
*
|
2010-02-11 |
2012-12-19 |
Ablynx N.V. |
Delivery of immunoglobulin variable domains and constructs thereof
|
US9180105B2
(en)
|
2010-03-08 |
2015-11-10 |
Sloan-Kettering Institute For Cancer Research |
CDC7 kinase inhibitors and uses thereof
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
EP3159331A1
(en)
|
2010-05-05 |
2017-04-26 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
WO2011140296A1
(en)
|
2010-05-05 |
2011-11-10 |
Infinity Pharmaceuticals |
Triazoles as inhibitors of fatty acid synthase
|
KR20130071433A
(en)
|
2010-05-07 |
2013-06-28 |
그린라이트 바이오사이언시스, 아이엔씨. |
Methods for control of flux in metabolic pathways through enzyme relocation
|
CN106977429B
(en)
|
2010-05-11 |
2021-08-24 |
蓝瑟斯医学影像公司 |
Compositions, methods and systems for synthesis and use of contrast agents
|
JP6022442B2
(en)
|
2010-05-14 |
2016-11-09 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
Male contraceptive compositions and methods of use
|
JP5857043B2
(en)
|
2010-06-18 |
2016-02-10 |
大鵬薬品工業株式会社 |
PRPK-TPRKB modulator and use thereof
|
EP4269563A3
(en)
|
2010-06-19 |
2024-01-10 |
Memorial Sloan-Kettering Cancer Center |
Anti-gd2 antibodies
|
WO2012009702A1
(en)
|
2010-07-15 |
2012-01-19 |
Corinthian Ophthalmic, Inc. |
Method and system for performing remote treatment and monitoring
|
US10154923B2
(en)
|
2010-07-15 |
2018-12-18 |
Eyenovia, Inc. |
Drop generating device
|
WO2012009696A2
(en)
|
2010-07-15 |
2012-01-19 |
Corinthian Ophthalmic, Inc. |
Ophthalmic drug delivery
|
CN103118642B
(en)
|
2010-07-15 |
2015-09-09 |
艾诺维亚股份有限公司 |
Drop formation device
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
KR20170058446A
(en)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
Peptidomimetic macrocycles
|
EP3219796B1
(en)
|
2010-08-31 |
2020-10-07 |
GreenLight Biosciences, Inc. |
Methods for control of flux in metabolic pathways through protease manipulation
|
EP2640405A4
(en)
|
2010-09-21 |
2015-04-15 |
Massachusetts Inst Technology |
Human-adapted ha polypeptides, vaccines, and influenza treatment
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
NZ608972A
(en)
|
2010-10-01 |
2015-09-25 |
Moderna Therapeutics Inc |
Engineered nucleic acids and methods of use thereof
|
AU2011312178B2
(en)
|
2010-10-04 |
2016-05-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
WO2012064973A2
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
GB201021716D0
(en)
*
|
2010-12-22 |
2011-02-02 |
Owen Mumford Ltd |
Autoinjectors
|
AR084824A1
(en)
|
2011-01-10 |
2013-06-26 |
Intellikine Inc |
PROCESSES TO PREPARE ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONAS
|
RU2587011C2
(en)
*
|
2011-01-10 |
2016-06-10 |
Зодженикс, Инк. |
Improved needle-free injectors
|
EP2982373B1
(en)
|
2011-01-19 |
2018-06-13 |
Topokine Therapeutics, Inc. |
Methods and compostions for reducing body fat
|
CN106924216A
(en)
|
2011-01-24 |
2017-07-07 |
安特里奥公司 |
Nanoparticulate compositions, its preparation and their purposes
|
EP2667945A1
(en)
|
2011-01-24 |
2013-12-04 |
Anterios, Inc. |
Oil compositions
|
BR112013018918A2
(en)
|
2011-01-24 |
2016-10-04 |
Anterios Inc |
nanoparticle compositions
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US9084849B2
(en)
|
2011-01-26 |
2015-07-21 |
Kaleo, Inc. |
Medicament delivery devices for administration of a medicament within a prefilled syringe
|
US8627816B2
(en)
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
EP2680837A4
(en)
|
2011-03-03 |
2015-06-03 |
Tersus Pharmaceuticals Llc |
COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9193767B2
(en)
|
2011-03-30 |
2015-11-24 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
MX339058B
(en)
|
2011-05-17 |
2016-05-09 |
Glaxosmithkline Biolog Sa |
Vaccine against streptococcus pneumoniae.
|
FR2976568B1
(en)
|
2011-06-14 |
2014-09-05 |
Valois Sas |
DEVICE FOR DISPENSING FLUID PRODUCT.
|
US9845327B2
(en)
|
2011-06-22 |
2017-12-19 |
The General Hospital Corporation |
Treatment of proteinopathies
|
WO2013009897A1
(en)
|
2011-07-11 |
2013-01-17 |
Medpro Safety Products, Inc. |
Fluid delivery device and methods
|
US8496619B2
(en)
|
2011-07-15 |
2013-07-30 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
US9220660B2
(en)
|
2011-07-15 |
2015-12-29 |
Antares Pharma, Inc. |
Liquid-transfer adapter beveled spike
|
JP6027611B2
(en)
|
2011-07-19 |
2016-11-16 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Heterocyclic compounds and uses thereof
|
EP2734520B1
(en)
|
2011-07-19 |
2016-09-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2013016193A2
(en)
|
2011-07-22 |
2013-01-31 |
Massachusetts Istitute Of Technology |
Activators of class i histone deacetlyases (hdacs) and uses thereof
|
US8785470B2
(en)
|
2011-08-29 |
2014-07-22 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TWI568714B
(en)
|
2011-09-09 |
2017-02-01 |
藍瑟斯醫學影像公司 |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
KR20150010932A
(en)
|
2011-09-09 |
2015-01-29 |
그린라이트 바이오사이언시스, 아이엔씨. |
Cell-free preparation of carbapenems
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
DE19216461T1
(en)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
MODIFIED NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS AND USES THEREOF
|
TW201806968A
(en)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
Peptidomimetic macrocycles
|
JP6106685B2
(en)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
Inhibitors of C-JUN-N-terminal kinase (JNK)
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2013090468A1
(en)
|
2011-12-12 |
2013-06-20 |
Corinthian Ophthalmic, Inc. |
High modulus polymeric ejector mechanism, ejector device, and methods of use
|
WO2013090648A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
AU2013221432B2
(en)
|
2012-02-15 |
2018-01-18 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
AU2013221433B2
(en)
|
2012-02-15 |
2018-01-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
EP2833944A4
(en)
|
2012-04-06 |
2016-05-25 |
Antares Pharma Inc |
Needle assisted jet injection administration of testosterone compositions
|
EP2850090B1
(en)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
US9273084B2
(en)
|
2012-04-06 |
2016-03-01 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP2850091A1
(en)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
US9364610B2
(en)
|
2012-05-07 |
2016-06-14 |
Antares Pharma, Inc. |
Injection device with cammed ram assembly
|
JP6431477B2
(en)
|
2012-05-10 |
2018-12-05 |
マサチューセッツ インスティテュート オブ テクノロジー |
Drugs for flu neutralization
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US9522235B2
(en)
|
2012-05-22 |
2016-12-20 |
Kaleo, Inc. |
Devices and methods for delivering medicaments from a multi-chamber container
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
WO2014042930A1
(en)
*
|
2012-09-17 |
2014-03-20 |
Hns International, Inc. |
Needleless hypodermic injector and related method
|
WO2014052647A2
(en)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Proline-locked stapled peptides and uses thereof
|
WO2014055564A1
(en)
|
2012-10-01 |
2014-04-10 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
JP6321662B2
(en)
|
2012-10-12 |
2018-05-09 |
ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. |
GSK3 inhibitor and method of use thereof
|
WO2014063068A1
(en)
|
2012-10-18 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
US9758522B2
(en)
|
2012-10-19 |
2017-09-12 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
US20140114248A1
(en)
*
|
2012-10-24 |
2014-04-24 |
Nuance Designs, LLC |
Power pack for an autoinjector
|
PL2914296T5
(en)
|
2012-11-01 |
2022-01-17 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
MX2015005244A
(en)
|
2012-11-01 |
2015-07-14 |
Aileron Therapeutics Inc |
Disubstituted amino acids and methods of preparation and use thereof.
|
EP2917203B1
(en)
|
2012-11-02 |
2019-04-03 |
Dana-Farber Cancer Institute, Inc. |
Method for identifying myc inhibitors
|
CN104936595A
(en)
|
2012-11-21 |
2015-09-23 |
托普凯恩制药公司 |
Methods and compositions for locally increasing body fat
|
EP2922575B1
(en)
|
2012-11-26 |
2019-06-26 |
President and Fellows of Harvard College |
Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
|
ES2921623T3
(en)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
terminally modified RNA
|
CA2899363A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
EP2935243B1
(en)
|
2012-12-21 |
2018-03-14 |
Epizyme, Inc. |
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
US8906900B2
(en)
|
2012-12-21 |
2014-12-09 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
WO2014100719A2
(en)
*
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
EP2938376A4
(en)
|
2012-12-27 |
2017-01-25 |
Kaleo, Inc. |
Devices, systems and methods for locating and interacting with medicament delivery systems
|
WO2014113089A2
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
JP6494527B2
(en)
|
2013-02-07 |
2019-04-03 |
ザ チルドレンズ メディカル センター コーポレーション |
Protein antigens that provide protection from pneumococcal colonization and / or disease
|
SG11201505744XA
(en)
|
2013-02-07 |
2015-08-28 |
Massachusetts Inst Technology |
Human adaptation of h5 influenza
|
EP2953667B1
(en)
|
2013-02-11 |
2019-10-23 |
Antares Pharma, Inc. |
Needle assisted jet injection device having reduced trigger force
|
WO2014164786A1
(en)
|
2013-03-11 |
2014-10-09 |
Madsen Patrick |
Dosage injector with pinion system
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
JP6568515B2
(en)
|
2013-03-13 |
2019-08-28 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Stapled and stitched polypeptides and uses thereof
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
JP6482525B2
(en)
|
2013-03-15 |
2019-03-13 |
メモリアル スローン ケタリング キャンサー センター |
High affinity anti-GD2 antibody
|
NZ629037A
(en)
|
2013-03-15 |
2017-04-28 |
Infinity Pharmaceuticals Inc |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
EP3760223A1
(en)
|
2013-04-03 |
2021-01-06 |
N-Fold Llc |
Nanoparticle composition for desensitizing a subject to peanut allergens
|
BR112015025159A2
(en)
|
2013-04-04 |
2017-07-18 |
Harvard College |
macrolides and methods for their preparation and use
|
EP2983659B1
(en)
|
2013-04-09 |
2019-11-20 |
Massachusetts Institute of Technology |
Drug delivery polymer and uses thereof
|
US10301359B2
(en)
|
2013-04-30 |
2019-05-28 |
Massachusetts Institute Of Technology |
Human adaptation of H3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(en)
|
2013-05-10 |
2018-06-16 |
|
|
US9820993B2
(en)
|
2013-05-15 |
2017-11-21 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
EP3811974A1
(en)
|
2013-05-30 |
2021-04-28 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
EP3030239A4
(en)
|
2013-06-11 |
2017-03-08 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
BR112015031277A2
(en)
|
2013-06-14 |
2017-09-19 |
Harvard College |
INSULIN RECEPTOR MODULATORS FROM STABILIZED POLYPEPTIDES, INSULIN ANALOGS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID POLYPEPTIDES AND METHODS OF PREPARATION AND USES THEREOF
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
KR20160034379A
(en)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
Inhibitors of transcription factors and uses thereof
|
KR20160040290A
(en)
|
2013-08-05 |
2016-04-12 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
Combination immunogenic compositions
|
EP3460069B1
(en)
|
2013-08-05 |
2021-10-20 |
Greenlight Biosciences, Inc. |
Therapeutically active compounds and their methods of use
|
AU2014317889B2
(en)
|
2013-09-06 |
2020-03-05 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
PL3052485T3
(en)
|
2013-10-04 |
2022-02-28 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2015057894A1
(en)
|
2013-10-15 |
2015-04-23 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
US9902986B2
(en)
|
2013-10-16 |
2018-02-27 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
AU2014337044A1
(en)
|
2013-10-18 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
US20160244452A1
(en)
|
2013-10-21 |
2016-08-25 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP3062618B1
(en)
|
2013-11-01 |
2020-02-05 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
CA2929652A1
(en)
|
2013-11-08 |
2015-05-14 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
WO2015070712A1
(en)
*
|
2013-11-14 |
2015-05-21 |
Abon Biopharm (Hangzhou) Co., Ltd. |
A device and method for using the device
|
TN2016000240A1
(en)
|
2013-12-24 |
2017-10-06 |
Harvard College |
Cortistatin analogues and syntheses and uses thereof.
|
CA2937123A1
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015184009A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
MX2016011160A
(en)
|
2014-02-28 |
2017-04-27 |
Tensha Therapeutics Inc |
Treatment of conditions associated with hyperinsulinaemia.
|
AU2015226911B2
(en)
|
2014-03-07 |
2018-03-01 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
|
JP6296840B2
(en)
*
|
2014-03-11 |
2018-03-20 |
テルモ株式会社 |
Liquid dosing device
|
JP6262030B2
(en)
*
|
2014-03-11 |
2018-01-17 |
テルモ株式会社 |
Liquid dosing device
|
CA2943075C
(en)
|
2014-03-19 |
2023-02-28 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
WO2015148915A1
(en)
|
2014-03-27 |
2015-10-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
ES2868305T3
(en)
|
2014-03-28 |
2021-10-21 |
Univ Washington Through Its Center For Commercialization |
Vaccines against breast and ovarian cancer
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
WO2015168380A1
(en)
|
2014-04-30 |
2015-11-05 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
CN111620940A
(en)
|
2014-05-21 |
2020-09-04 |
哈佛大学的校长及成员们 |
RAS inhibitory peptides and uses thereof
|
US10005847B2
(en)
|
2014-05-27 |
2018-06-26 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
JP2017518989A
(en)
|
2014-05-27 |
2017-07-13 |
アカデミア シニカAcademia Sinica |
Anti-CD20 glycoengineered antibody group and use thereof
|
US11332523B2
(en)
|
2014-05-28 |
2022-05-17 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
EP3152694B1
(en)
|
2014-06-03 |
2024-03-06 |
Amgen Inc. |
Systems and methods for remotely processing data collected by a drug delivery device
|
CA2951430A1
(en)
|
2014-06-13 |
2015-12-17 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
IL274159B2
(en)
|
2014-06-19 |
2024-03-01 |
Ariad Pharma Inc |
Heteroaryl compounds for kinase inhibition
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
EP3164379A1
(en)
|
2014-07-02 |
2017-05-10 |
Massachusetts Institute of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
MX2017000624A
(en)
*
|
2014-07-15 |
2017-10-02 |
Alcon Pharmaceuticals Ltd |
Intraocular lens inserter with temperature compensation.
|
EP3169699A4
(en)
|
2014-07-18 |
2018-06-20 |
The University of Washington |
Cancer vaccine compositions and methods of use thereof
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
WO2018140026A1
(en)
|
2017-01-27 |
2018-08-02 |
Memorial Sloan Kettering Cancer Center |
Bispecific her2 and cd3 binding molecules
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
CN104162207A
(en)
*
|
2014-08-27 |
2014-11-26 |
苏州承乐电子科技有限公司 |
Continuous type needleless injector
|
AU2015315294B2
(en)
|
2014-09-08 |
2020-09-17 |
Academia Sinica |
Human iNKT cell activation using glycolipids
|
CN112245565A
(en)
|
2014-09-24 |
2021-01-22 |
艾瑞朗医疗公司 |
Peptidomimetic macrocycles and uses thereof
|
CN107106642B
(en)
|
2014-09-24 |
2021-02-26 |
艾瑞朗医疗公司 |
Peptidomimetic macrocycles and formulations thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
CN107108559B
(en)
|
2014-10-21 |
2020-06-05 |
阿瑞雅德制药公司 |
Crystalline forms of 5-chloro-N4- [2- (dimethylphosphoryl) phenyl ] -N2- { 2-methoxy-4- [4- (4-methylpiperazin-1-yl) piperidin-1-yl ] phenyl } pyrimidine-2, 4-diamine
|
US10124009B2
(en)
|
2014-10-27 |
2018-11-13 |
Tensha Therapeutics, Inc. |
Bromodomain inhibitors
|
US20180015101A1
(en)
|
2014-10-28 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
EP3041948B1
(en)
|
2014-11-10 |
2019-01-09 |
Modernatx, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
EP3230272B1
(en)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
JP2017538512A
(en)
|
2014-12-19 |
2017-12-28 |
アムジエン・インコーポレーテツド |
Drug delivery device including live button or user interface field
|
EP3233163B1
(en)
|
2014-12-19 |
2021-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
KR102554779B1
(en)
|
2014-12-23 |
2023-07-11 |
슬로안-케테링인스티튜트퍼캔서리서치 |
Polymorph of granaticin b
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
EP3789766A1
(en)
|
2015-01-24 |
2021-03-10 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
RU2758113C2
(en)
|
2015-03-17 |
2021-10-26 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Antibodies to muc16 and their application
|
CA2979847A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
AU2016235054B2
(en)
|
2015-03-24 |
2020-07-16 |
Kaleo, Inc. |
Devices and methods for delivering a lyophilized medicament
|
EP3273966B1
(en)
|
2015-03-27 |
2023-05-03 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
JP6843065B2
(en)
|
2015-03-30 |
2021-03-17 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
Cell-free production of ribonucleic acid
|
KR20170140306A
(en)
|
2015-04-27 |
2017-12-20 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
Metabolically programmed metal chelating agents and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
PT3310764T
(en)
|
2015-06-19 |
2023-07-11 |
Massachusetts Inst Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
GB2556479B
(en)
|
2015-06-30 |
2022-09-07 |
Kaleo Inc |
Auto-injectors for administration of a medicament within a prefilled syringe
|
WO2017004548A1
(en)
|
2015-07-01 |
2017-01-05 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
WO2017044633A1
(en)
|
2015-09-10 |
2017-03-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of mcl-1
|
AU2016324463B2
(en)
|
2015-09-17 |
2022-10-27 |
Modernatx, Inc. |
Polynucleotides containing a stabilizing tail region
|
PT3350157T
(en)
|
2015-09-17 |
2022-03-18 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of therapeutic agents
|
EP3355882A1
(en)
|
2015-10-01 |
2018-08-08 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US10799463B2
(en)
|
2015-12-22 |
2020-10-13 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
US10336784B2
(en)
|
2016-03-08 |
2019-07-02 |
Academia Sinica |
Methods for modular synthesis of N-glycans and arrays thereof
|
US10918808B2
(en)
*
|
2016-03-09 |
2021-02-16 |
Portal Instruments, Inc. |
Angled injection nozzle
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
CA3019164A1
(en)
|
2016-03-29 |
2017-10-05 |
Janssen Biotech, Inc. |
Method of treating psoriasis with increased interval dosing of anti-il12/23 antibody
|
AU2017246458B2
(en)
|
2016-04-06 |
2022-08-11 |
Greenlight Biosciences, Inc. |
Cell-free production of ribonucleic acid
|
US9907904B2
(en)
|
2016-05-10 |
2018-03-06 |
Burton H. Sage, Jr. |
Spring-driven drug delivery device
|
TW201803615A
(en)
*
|
2016-05-31 |
2018-02-01 |
賽諾菲阿凡提斯德意志有限公司 |
Button for a drug delivery device and method for assembling a button for a drug delivery device
|
TWI729141B
(en)
*
|
2016-05-31 |
2021-06-01 |
德商賽諾菲阿凡提斯德意志有限公司 |
Cap assembly for a drug delivery device and method for assembling a cap assembly
|
CA3026094A1
(en)
|
2016-06-03 |
2017-12-07 |
Sanofi Pasteur Inc. |
Modification of engineered influenza hemagglutinin polypeptides
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
JP2019525901A
(en)
|
2016-06-14 |
2019-09-12 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
Stabilized preparation of lipid nanoparticles
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
MX2019000643A
(en)
|
2016-07-15 |
2019-06-13 |
Poseida Therapeutics Inc |
Chimeric antigen receptors and methods for use.
|
WO2018014039A1
(en)
|
2016-07-15 |
2018-01-18 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors (cars) specific for muc1 and methods for their use
|
TWI770044B
(en)
|
2016-08-05 |
2022-07-11 |
南韓商Sk生物科技股份有限公司 |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CN109862908B
(en)
|
2016-08-05 |
2023-05-02 |
圣诺菲·帕斯图尔公司 |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
KR102588027B1
(en)
|
2016-08-22 |
2023-10-12 |
초 파마 인크. |
Antibodies, binding fragments and methods of use
|
CA3037961A1
(en)
|
2016-09-30 |
2018-04-05 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il23 specific antibody
|
WO2018089540A1
(en)
|
2016-11-08 |
2018-05-17 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
MX2019005661A
(en)
|
2016-11-16 |
2019-10-07 |
Janssen Biotech Inc |
Method of treating psoriasis with anti-il-23 specific antibody.
|
CN106668992B
(en)
*
|
2016-11-28 |
2019-07-12 |
合肥讯创信息科技有限公司 |
It is pressurized Needleless injection device
|
CN107050580B
(en)
*
|
2016-11-28 |
2019-12-31 |
大连医科大学附属第二医院 |
Automatic reset needleless injector with pressurization function
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
JP7014797B2
(en)
|
2016-12-23 |
2022-02-01 |
カレオ,インコーポレイテッド |
Drug delivery devices and methods for delivering drugs to babies and children
|
AU2018210313A1
(en)
|
2017-01-17 |
2019-06-20 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and event detection
|
CN110234351A
(en)
|
2017-01-30 |
2019-09-13 |
詹森生物科技公司 |
For treating the anti-TNF antibodies, composition and method of activity psoriatic arthritis
|
GB2559553B
(en)
*
|
2017-02-06 |
2021-10-13 |
Consort Medical Plc |
A medicament delivery device
|
MX2019009377A
(en)
|
2017-02-07 |
2019-12-11 |
Janssen Biotech Inc |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis.
|
EP3595727A1
(en)
|
2017-03-15 |
2020-01-22 |
ModernaTX, Inc. |
Lipid nanoparticle formulation
|
WO2018170306A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
EP3601326A4
(en)
|
2017-03-20 |
2020-12-16 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
EP3634550A4
(en)
|
2017-06-10 |
2021-03-03 |
Eyenovia, Inc. |
Methods and devices for handling a fluid and delivering the fluid to the eye
|
EP3638678A1
(en)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
CN107252512B
(en)
*
|
2017-06-16 |
2018-03-13 |
南阳市中心医院 |
A kind of gas-driven needle-less syringe
|
SG11201912601RA
(en)
|
2017-06-23 |
2020-01-30 |
Nosocomial Vaccine Corp |
Immunogenic compositions
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds and uses thereof
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds
|
WO2019040399A1
(en)
|
2017-08-22 |
2019-02-28 |
Shire-Nps Pharmaceuticals, Inc. |
Glp-2 fusion polypeptides and uses for treating and preventing gastrointestinal conditions
|
US11318253B2
(en)
*
|
2017-08-29 |
2022-05-03 |
Clear Dart, L.L.C. |
Dart syringe projectile
|
KR101862201B1
(en)
*
|
2017-08-31 |
2018-05-29 |
제이에스케이바이오메드(주) |
Micro-jet drug injection device with backflow prevention valve
|
US11744801B2
(en)
|
2017-08-31 |
2023-09-05 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
EP3679145A2
(en)
|
2017-09-08 |
2020-07-15 |
Poseida Therapeutics, Inc. |
Compositions and methods for chimeric ligand receptor (clr)-mediated conditional gene expression
|
TW201922780A
(en)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
Safe and effective method of treating Lupus with anti-IL12/IL23 antibody
|
IL273887B
(en)
|
2017-10-11 |
2022-09-01 |
Greenlight Biosciences Inc |
Methods and compositions for nucleoside triphosphate and ribonucleic acid production
|
WO2019109079A1
(en)
|
2017-12-01 |
2019-06-06 |
North Carolina State University |
Fibrin particles and methods of making the same
|
AU2018393110B2
(en)
|
2017-12-20 |
2023-04-27 |
Poseida Therapeutics, Inc. |
VCAR compositions and methods for use
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
KR101859735B1
(en)
*
|
2018-02-07 |
2018-05-21 |
주식회사 피테크 |
Painless injection device
|
EP3762015A4
(en)
|
2018-03-05 |
2022-04-27 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
MX2020009309A
(en)
|
2018-03-07 |
2021-01-08 |
Poseida Therapeutics Inc |
Cartyrin compositions and methods for use.
|
WO2019197325A1
(en)
*
|
2018-04-09 |
2019-10-17 |
Becton Dickinson France |
Medical injection system
|
EP3790587A4
(en)
|
2018-05-11 |
2022-01-26 |
Janssen Biotech, Inc. |
Methods of treating depression using il-23 antibodies
|
WO2020018433A1
(en)
|
2018-07-16 |
2020-01-23 |
Kaleo, Inc. |
Medicament delivery devices with wireless connectivity and compliance detection
|
WO2020016838A2
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained response predictors after treatment with anti-il23 specific antibody
|
EP3853202A1
(en)
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
EP3852728A1
(en)
|
2018-09-20 |
2021-07-28 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
FI3883606T3
(en)
|
2018-09-24 |
2023-09-07 |
Janssen Biotech Inc |
Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody
|
US11548941B2
(en)
|
2018-11-20 |
2023-01-10 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
JP2022513507A
(en)
|
2018-12-20 |
2022-02-08 |
ポセイダ セラピューティクス,インコーポレイティド |
Nanotransposon composition and usage
|
AU2020208828A1
(en)
|
2019-01-15 |
2021-08-05 |
Janssen Biotech, Inc. |
Anti-TNF antibody compositions and methods for the treatment of juvenile idiopathic arthritis
|
CN113924292A
(en)
|
2019-01-16 |
2022-01-11 |
库扎环球有限责任公司 |
Antimicrobial compounds and methods
|
EP3911643A1
(en)
|
2019-01-16 |
2021-11-24 |
Curza Global LLC |
Antimicrobial compounds and methods
|
CA3127748A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
AU2020216361A1
(en)
|
2019-01-29 |
2021-08-12 |
Sujit JAIN |
Parathyroid hormone variants
|
WO2020160397A1
(en)
|
2019-01-31 |
2020-08-06 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
CA3133388A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
WO2020183269A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CN113825765A
(en)
|
2019-03-14 |
2021-12-21 |
詹森生物科技公司 |
Method for producing anti-IL 12/IL23 antibody composition
|
US20220144934A1
(en)
|
2019-03-14 |
2022-05-12 |
Janssen Biotech, Inc. |
Methods for Producing Anti-TNF Antibody Compositions
|
EA202192459A1
(en)
|
2019-03-18 |
2021-11-25 |
Янссен Байотек, Инк. |
METHOD FOR TREATMENT OF PSORIASIS WITH ANTIBODY TO IL12 / IL23 IN CHILDREN
|
CA3138241A1
(en)
|
2019-05-23 |
2020-11-26 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
MX2021014885A
(en)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech Inc |
Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis.
|
JP2022535534A
(en)
|
2019-06-03 |
2022-08-09 |
ヤンセン バイオテツク,インコーポレーテツド |
Anti-TNF Antibodies, Compositions and Methods for Treating Active Ankylosing Spondylitis
|
JP2022543773A
(en)
|
2019-07-31 |
2022-10-14 |
モデルナティエックス インコーポレイテッド |
Compositions and methods for delivery of RNA interfering agents to immune cells
|
JP2022542316A
(en)
|
2019-07-31 |
2022-09-30 |
サノフィ パスツール インコーポレイテッド |
Polyvalent pneumococcal polysaccharide-protein conjugate compositions and methods of use thereof
|
JP2022543523A
(en)
|
2019-08-09 |
2022-10-13 |
カレオ,インコーポレイテッド |
Device and method for delivery of substances in pre-filled syringes
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CN114761424A
(en)
|
2019-09-05 |
2022-07-15 |
波赛达治疗公司 |
Allogeneic cell compositions and methods of use
|
CN110882447A
(en)
*
|
2019-11-11 |
2020-03-17 |
徐州深丰精密机械有限公司 |
Medical syringe assembly
|
CN115297930A
(en)
|
2019-11-13 |
2022-11-04 |
库扎环球有限责任公司 |
Antimicrobial compounds and methods
|
CN115135672A
(en)
|
2019-12-20 |
2022-09-30 |
波赛达治疗公司 |
anti-MUC 1 compositions and methods of use
|
EP4096644A1
(en)
|
2020-01-31 |
2022-12-07 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
US11642407B2
(en)
|
2020-02-28 |
2023-05-09 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
JP2023515692A
(en)
|
2020-03-04 |
2023-04-13 |
ポセイダ セラピューティクス,インコーポレイティド |
Compositions and methods for the treatment of metabolic liver injury
|
WO2021183795A1
(en)
|
2020-03-11 |
2021-09-16 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
MX2022012956A
(en)
|
2020-04-14 |
2023-03-27 |
Poseida Therapeutics Inc |
Compositions and methods for use in the treatment of cancer.
|
WO2021214587A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating viral infections
|
WO2021214588A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating coronavirus infections
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
US20240000969A1
(en)
|
2020-10-21 |
2024-01-04 |
Poseida Therapeutics San Diego |
Compositions and methods for delivery of nucleic acids
|
US20230174576A1
(en)
|
2020-10-30 |
2023-06-08 |
Xeno-Interface Inc. |
Beta-strand bridge peptide
|
JPWO2022092294A1
(en)
|
2020-10-30 |
2022-05-05 |
|
|
TW202237068A
(en)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
High-throughput methods for preparing lipid nanoparticles and uses thereof
|
KR102611990B1
(en)
*
|
2021-02-19 |
2023-12-11 |
(주)바이오시드 |
One touch type of semi-automatic needle-less injector using gas pressure
|
US20240060090A1
(en)
|
2021-02-23 |
2024-02-22 |
Poseida Therapeutics, Inc. |
Genetically modified induced pluripotent stem cells and methods of use thereof
|
JP2024507846A
(en)
|
2021-02-23 |
2024-02-21 |
ポセイダ セラピューティクス,インコーポレイティド |
Compositions and methods for delivery of nucleic acids
|
WO2022187671A1
(en)
|
2021-03-04 |
2022-09-09 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
US20220287983A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
BR112023018400A2
(en)
|
2021-03-12 |
2023-12-12 |
Janssen Biotech Inc |
METHOD FOR TREATMENT OF PSORIATIC ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNF THERAPY WITH SPECIFIC ANTI-IL23 ANTIBODY
|
IL305802A
(en)
|
2021-03-12 |
2023-11-01 |
Janssen Biotech Inc |
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
|
TW202313065A
(en)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
Compounds for treating genetic diseases
|
AU2022306144A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
AU2022308201A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
IL309987A
(en)
|
2021-07-09 |
2024-03-01 |
Janssen Biotech Inc |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
KR102582365B1
(en)
*
|
2021-08-05 |
2023-09-25 |
(주)씨엔엘바이오텍 |
needleless syringe container
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
US20230233667A1
(en)
|
2021-09-08 |
2023-07-27 |
Affinivax, Inc. |
Coronavirus vaccine
|
WO2023060089A2
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposases and uses thereof
|
WO2023060088A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
TW202333778A
(en)
|
2021-10-08 |
2023-09-01 |
美商賽諾菲巴斯德公司 |
Multivalent influenza vaccines
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
WO2023084488A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
US20230159633A1
(en)
|
2021-11-23 |
2023-05-25 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|
TW202333654A
(en)
|
2021-12-16 |
2023-09-01 |
美商現代公司 |
Processes for preparing lipid nanoparticles
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023141576A1
(en)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023164573A1
(en)
|
2022-02-23 |
2023-08-31 |
Poseida Therapeutics, Inc. |
Genetically modified cells and methods of use thereof
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
US20230312703A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis with IL-23 Specific Antibody
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
US20230374122A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024036273A1
(en)
|
2022-08-11 |
2024-02-15 |
Poseida Therapeutics, Inc. |
Chimeric cd8-alpha co-receptor compositions and methods of use
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|